Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

MARK3 Antikörper (C-Term)

MARK3 Reaktivität: Human WB, IHC (p) Wirt: Kaninchen Polyclonal unconjugated
Produktnummer ABIN5534501
  • Target Alle MARK3 Antikörper anzeigen
    MARK3 (MAP/microtubule Affinity-Regulating Kinase 3 (MARK3))
    Bindungsspezifität
    • 14
    • 8
    • 6
    • 6
    • 5
    • 4
    • 4
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 570-601, C-Term
    Reaktivität
    • 62
    • 28
    • 19
    • 4
    • 3
    • 3
    • 3
    • 3
    • 3
    • 3
    • 1
    • 1
    Human
    Wirt
    • 53
    • 8
    • 1
    Kaninchen
    Klonalität
    • 55
    • 7
    Polyklonal
    Konjugat
    • 36
    • 5
    • 5
    • 4
    • 3
    • 3
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser MARK3 Antikörper ist unkonjugiert
    Applikation
    • 40
    • 31
    • 20
    • 6
    • 6
    • 6
    • 2
    • 2
    • 1
    • 1
    • 1
    Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
    Aufreinigung
    This antibody is purified through a protein A column, followed by peptide affinity purification.
    Immunogen
    This MARK3 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 570-601 amino acids from the C-terminal region of human MARK3.
    Isotyp
    Ig Fraction
    Top Product
    Discover our top product MARK3 Primärantikörper
  • Applikationshinweise
    For IHC-P starting dilution is: 1:50~100

    For WB starting dilution is: 1:1000
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Konzentration
    0.5 mg/mL
    Buffer
    Supplied in PBS with 0.09 % (W/V) sodium azide.
    Konservierungsmittel
    Sodium azide
    Vorsichtsmaßnahmen
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Lagerung
    4 °C,-20 °C
    Informationen zur Lagerung
    Store at 4°C for three months and -20°C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.
  • Target
    MARK3 (MAP/microtubule Affinity-Regulating Kinase 3 (MARK3))
    Andere Bezeichnung
    MARK3 (MARK3 Produkte)
    Synonyme
    MARK3 antikoerper, par1 antikoerper, par-1 antikoerper, Par-1A antikoerper, CTAK1 antikoerper, KP78 antikoerper, PAR1A antikoerper, Par-1a antikoerper, 1600015G02Rik antikoerper, A430080F22Rik antikoerper, C-TAK1 antikoerper, ETK-1 antikoerper, ETK1 antikoerper, Emk2 antikoerper, MPK10 antikoerper, fi39g08 antikoerper, wu:fi39g08 antikoerper, zgc:152848 antikoerper, zgc:55693 antikoerper, c-tak1 antikoerper, ctak1 antikoerper, emk-2 antikoerper, microtubule affinity regulating kinase 3 antikoerper, MAP/microtubule affinity-regulating kinase 3b antikoerper, MAP/microtubule affinity regulating kinase 3 antikoerper, MAP/microtubule affinity-regulating kinase 3a antikoerper, microtubule affinity regulating kinase 3 L homeolog antikoerper, MARK3 antikoerper, mark3b antikoerper, mark3 antikoerper, Mark3 antikoerper, mark3a antikoerper, mark3.L antikoerper
    Hintergrund
    MARK proteins are involved in the specific phosphorylation of microtubule-associated proteins for tau, MAP2, and MAP4. MARK3 was originally identified as a marker that was induced by treatment with DNA damaging agents, and loss of MARK3 was found with carcinogenesis in the pancreas. MARK3 may be involved in cell cycle regulation, and alterations in the MARK3 gene may lead to carcinogenesis.
    Molekulargewicht
    84 kDa
    Gen-ID
    4140
    UniProt
    P27448
    Pathways
    SARS-CoV-2 Protein Interaktom
Sie sind hier:
Kundenservice